Free medication will soon be provided to low-income cancer patients in the UAE.
It comes following a new agreement between the Ministry of Health and Prevention (MoHAP) and pharmaceutical company, AstraZeneca.
The initiative will benefit those battling bladder and lung cancer as well as patients with lymphoma and acute asthma.
Commenting on the agreement, Leon Wang, Executive VP at International AstraZeneca said: "This initiative, which includes new and innovative treatment for some types of cancer and respiratory diseases, would help patients, who are under limited medical insurance."
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department said that the initiative would help enhance community responsibility values for companies.
UAE expands support for Gaza healthcare system
H.H. Sheikh Khaled approves AED1.54 billion in housing benefits
Dubai Police crack down on beggars and illegal butchers
UAE, Saudi Arabia and allies condemn Israeli minister over flotilla detainees
UAE President joins call with Trump, regional leaders to discuss Iran peace deal
